ParkerVision Reports Improved Net Loss of $1.6 Million for Q1 2026

ParkerVision, Inc. reported a net loss of approximately $1.6 million for the three months ended March 31, 2026, a significant improvement compared to a net loss of $3.8 million during the same period in 2025. The company did not recognize any licensing revenue in either period, and its total operating expenses decreased to $958,000 from $1.2 million year-over-year. The reduction in expenses was primarily attributed to lower outside professional fees, including litigation-related costs, which fell by approximately $0.3 million. The basic and diluted loss per share for the first quarter of 2026 was $0.01, compared to $0.03 in the prior year.

ParkerVision's total assets decreased to $4.5 million as of March 31, 2026, down from $5.4 million at the end of 2025. Current liabilities also saw a decline, falling to $2.1 million from $2.4 million, largely due to a reduction in convertible notes payable. The company’s accumulated deficit increased to approximately $457.2 million, reflecting ongoing challenges in generating revenue from its patent enforcement actions. The working capital at the end of the first quarter was $1.7 million, a decrease of $0.5 million from the previous quarter.

In terms of strategic developments, ParkerVision entered into exchange agreements on March 13, 2026, with certain holders of its convertible promissory notes, resulting in the issuance of approximately 3.3 million shares of common stock in exchange for the cancellation of notes totaling $0.7 million. This move is part of the company's ongoing efforts to manage its debt and improve its capital structure. The company continues to focus on patent enforcement actions against various technology firms, including Qualcomm and MediaTek, with several trials postponed pending updates to expert reports.

Operationally, ParkerVision has not reported any significant changes in customer counts or user statistics, as its revenue generation remains tied to the outcomes of its patent litigation efforts. The company has ongoing patent enforcement actions in various U.S. district courts, which are critical to its business model. As of March 31, 2026, ParkerVision had approximately $3.4 million in cash and cash equivalents, indicating a need for additional capital to meet its liquidity requirements over the next twelve months.

Looking ahead, ParkerVision acknowledges substantial doubt about its ability to continue as a going concern without additional financing. The company anticipates that proceeds from patent enforcement actions and technology licenses may not be sufficient to cover its working capital needs. Management is focused on negotiating licensing agreements and controlling operating costs while exploring options for additional capital through debt or equity financing. The future performance of ParkerVision will largely depend on the outcomes of its ongoing litigation and the ability to secure new licensing agreements.